Rigel Pharmaceuticals (RIGL) Treasury Shares (2021 - 2026)

Rigel Pharmaceuticals has reported Treasury Shares for 6 years, with the latest figure at $67200.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 88.17% year-over-year to $67200.0; the trailing twelve-month figure through Mar 2026 stood at $67200.0 (down 88.17% YoY), and the FY2025 full-year result was $607621.0, up 56.89% from the prior year.
• Treasury Shares for Q1 2026 stood at $67200.0, down from $607621.0 in the prior quarter.
• The five-year high for Treasury Shares was $4.1 million in Q1 2024, with the low at $67200.0 in Q1 2026.
• Average Treasury Shares over 5 years is $1.1 million, with a median of $607621.0 recorded in 2025.
• Year-over-year, Treasury Shares jumped 387.8% in 2022 and plunged 88.17% in 2026.
• Tracing RIGL's Treasury Shares over 5 years: stood at $1.1 million in 2022, then plunged by 83.15% to $185938.0 in 2023, then surged by 108.29% to $387282.0 in 2024, then jumped by 56.89% to $607621.0 in 2025, then sank by 88.94% to $67200.0 in 2026.
• The last three Treasury Shares figures came in at $67200.0 (Q1 2026), $607621.0 (Q4 2025), and $569106.0 (Q3 2025), per Business Quant data.

Peer Comparison